INS and type 2 diabetes mellitus: In tumour-bearing mice, insulin insensitivity preceded weight loss and administration of Rosiglitazone, a drug used in the treatment of type 2 diabetes, improved insulin sensitivity and attenuated skeletal muscle proteolysis (Asp et al, 2010).